Sherlock Biosciences
The Future of Molecular Diagnostics
- Headquarters
- Watertown, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Website
- sherlock.bio
About
Sherlock Biosciences develops CRISPR-based and synthetic biology diagnostic platforms for rapid, affordable molecular testing at the point of need. The company's proprietary SHERLOCK and INSPECTR platforms enable detection of DNA and RNA targets for applications including infectious disease, cancer, and STI testing. In 2020, Sherlock received the first FDA Emergency Use Authorization for a CRISPR-based diagnostic.
Summary
Sherlock Biosciences is a Biotech company based in Watertown, United States.
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.